{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T09:20:14Z","timestamp":1788081614373,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.pcl.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T02:49:53Z","timestamp":1527130193000},"page":"527-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["von Willebrand Disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Christopher J.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2018.02.004_bib1","first-page":"7","article-title":"Hereditar pseudohemofili","volume":"67","author":"Willebrand von","year":"1926","journal-title":"Finska Lakarsallskapets"},{"issue":"13","key":"10.1016\/j.pcl.2018.02.004_bib2","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.pcl.2018.02.004_bib3","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pcl.2018.02.004_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pcl.2018.02.004_bib5","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI112129","article-title":"Substructure of human von Willebrand factor","volume":"76","author":"Fowler","year":"1985","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.pcl.2018.02.004_bib6","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood.V98.6.1662","article-title":"Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family","volume":"98","author":"Fujikawa","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.pcl.2018.02.004_bib7","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pcl.2018.02.004_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1538-7836.2005.01245.x","article-title":"Provisional criteria for the diagnosis of VWD type 1: on behalf of the ISTH SSC Subcommittee on von Willebrand factor","volume":"3","author":"Sadler","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.pcl.2018.02.004_bib9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A\u00a0quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"10.1016\/j.pcl.2018.02.004_bib10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2011.04265.x","article-title":"Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation","volume":"9","author":"Tosetto","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pcl.2018.02.004_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/asheducation.V2012.1.152.3798226","article-title":"Bleeding scores: are they really useful?","volume":"2012","author":"O'Brien","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.pcl.2018.02.004_bib12","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1538-7836.2008.03182.x","article-title":"Generation and validation of the condensed MCMDM-1VWD bleeding questionnaire for von Willebrand disease","volume":"6","author":"Bowman","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"8","key":"10.1016\/j.pcl.2018.02.004_bib13","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2009.03499.x","article-title":"Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire","volume":"7","author":"Bowman","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"issue":"26","key":"10.1016\/j.pcl.2018.02.004_bib14","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1182\/blood-2014-02-557264","article-title":"The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease","volume":"123","author":"Federici","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2018.02.004_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-0037-1614035","article-title":"von Willebrand disease in a pediatric-based population\u2013comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor\/collagen-binding assay","volume":"84","author":"Dean","year":"2000","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.pcl.2018.02.004_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1160\/TH03-01-0004","article-title":"Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice","volume":"90","author":"Posan","year":"2003","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.pcl.2018.02.004_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2010.08333.x","article-title":"The impact of bleeding history, von Willebrand factor and PFA-100\u00ae on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD","volume":"151","author":"Castaman","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.pcl.2018.02.004_bib18","first-page":"35","article-title":"Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease","volume":"82","author":"Cattaneo","year":"1999","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.pcl.2018.02.004_bib19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bod\u00f3","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"issue":"18","key":"10.1016\/j.pcl.2018.02.004_bib20","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2012-12-471672","article-title":"No increase in bleeding identified in type 1\u00a0VWD subjects with D1472H sequence variation","volume":"121","author":"Flood","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.pcl.2018.02.004_bib21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1538-7836.2012.04747.x","article-title":"Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease","volume":"10","author":"Flood","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.pcl.2018.02.004_bib22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1373\/clinchem.2012.199000","article-title":"Collagen binding provides a sensitive screen for variant von Willebrand disease","volume":"59","author":"Flood","year":"2013","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.pcl.2018.02.004_bib23","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF: CB in diagnosis of VWD","volume":"8","author":"Flood","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"10.1016\/j.pcl.2018.02.004_bib24","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pcl.2018.02.004_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V75.1.20.20","article-title":"A\u00a0new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF\/FVIII interaction","volume":"75","author":"Mazurier","year":"1990","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.pcl.2018.02.004_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand's disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.pcl.2018.02.004_bib27","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI111112","article-title":"von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease","volume":"72","author":"Miller","year":"1983","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.pcl.2018.02.004_bib28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/pbc.24860","article-title":"FVIII\/VWF ratio is not a reliable predictor of VWD in children","volume":"61","author":"Branchford","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.pcl.2018.02.004_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0049-3848(77)90090-1","article-title":"Effect of exercise on F VIII-complex: proportional increase of ristocetin cofactor (Von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF","volume":"10","author":"Stibbe","year":"1977","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.pcl.2018.02.004_bib30","first-page":"94","article-title":"Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment","volume":"88","author":"Castaman","year":"2003","journal-title":"Haematologica"},{"issue":"15","key":"10.1016\/j.pcl.2018.02.004_bib31","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2015-04-512731","article-title":"von Willebrand factor propeptide: biology and clinical utility","volume":"126","author":"Haberichter","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pcl.2018.02.004_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.pcl.2018.02.004_bib33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2009.1.106","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease","author":"Sadler","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.pcl.2018.02.004_bib34","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.pcl.2018.02.004_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/jth.12226","article-title":"Clearance of von Willebrand factor","volume":"11","author":"Casari","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.pcl.2018.02.004_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pcl.2018.02.004_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/beha.2001.0138","article-title":"Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology","volume":"14","author":"Mazurier","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"10","key":"10.1016\/j.pcl.2018.02.004_bib38","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"7","key":"10.1016\/j.pcl.2018.02.004_bib39","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.pcl.2018.02.004_bib40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.pcl.2018.02.004_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-2006-949668","article-title":"Comparative analysis and classification of von Willebrand factor\/factor VIII concentrates: impact on treatment of patients with von Willebrand disease","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"17","key":"10.1016\/j.pcl.2018.02.004_bib42","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Ragni","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pcl.2018.02.004_bib43","first-page":"378","article-title":"Venous thromboembolism in von Willebrand disease","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.pcl.2018.02.004_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-2006-949667","article-title":"Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3","volume":"32","author":"Berntorp","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 5","key":"10.1016\/j.pcl.2018.02.004_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2516.2008.01851.x","article-title":"Prophylaxis in von Willebrand disease","volume":"14","author":"Berntorp","year":"2008","journal-title":"Haemophilia"},{"issue":"9","key":"10.1016\/j.pcl.2018.02.004_bib46","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.12995","article-title":"Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand disease prophylaxis network","volume":"13","author":"Abshire","year":"2015","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395518300269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395518300269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T08:03:53Z","timestamp":1571385833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395518300269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0031395518300269"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2018.02.004","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"von Willebrand Disease","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}